A
Agilent Technologies Inc.
$159.00
장중 · Vol 125.7K · 52주 $108.35–$163.75 · 기준 2026. 8. 21. PM 3:59 ET
일봉 $153.12 · Aug 31, 2026
A 가격 추세
종가
$153.12
시가
$152.68
고가
$153.39
저가
$151.63
30초 브리핑
A 오늘의 판단 요약
보유 데이터를 비교 가능한 문장으로 해석한 요약입니다.
52주 범위의 91%
연중 고점권입니다. 추세 강도와 돌파 실패 위험을 함께 확인하세요.
Forward P/E 22.7배
선행 P/E가 낮아 시장은 이익 증가를 반영하고 있습니다.
20일 평균의 2.0배
평소보다 거래가 활발해 가격 움직임의 확인 강도가 높습니다.
2026-11-25
실적 전후 변동성 확대 가능성이 있으므로 컨센서스 범위와 옵션 기대변동을 함께 보세요.
펀더멘털 기준 Sep 1, 2026 · 규칙 기반 요약이며 투자 조언이 아닙니다.
핵심 통계
A 일봉·펀더멘털 스냅샷 기준 주요 지표
펀더멘털 스냅샷 Sep 1, 2026
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
5301 Stevens Creek Boulevard · Santa Clara, CA, United States · 직원 18,000명
시가총액
$43.30B
Trailing P/E
30.2
최근 12개월 이익 기준
Forward P/E
22.7
이익 증가 기대 반영
EPS (TTM)
$5.08
배당 수익률
0.66%
배당성향
20.0%
베타
1.23
시장보다 민감
ROE
21.0%
P/B
5.88
EV/EBITDA
21.7
52주 범위
$108.35 – $163.75
현재 위치 91%
거래량
2.73M
20일 평균 1.35M · 2.0배
애널리스트 의견
매수 73%
총 22명 · 0m
DITM LEAPS Analysis
A 장기 DITM 콜옵션을 진입 적합도 순으로 비교
| Contract | Expiry | Strike | Price | Lev. | Delta | Extrinsic | Spread | IV | OI | Score | 상세 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A270917C00130000 | 9/17/27 · 1.0Y | $130.00 | $38.00 | 3.0x | 0.7527 | 38.0% | 13.16% | 47.40% | 4 | 49.84 |
재무제표
A 연간 손익·현금흐름·재무상태
매출 성장률
+6.7%
최근 연간 YoY
EPS 성장률
+3.2%
최근 연간 YoY
영업이익률
21.3%
최근 연간
FCF 마진
16.6%
잉여현금흐름 / 매출
매출 추세
순이익 추세
잉여현금흐름 추세
| 항목 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| 매출 | $6.95B+6.7% | $6.51B-4.7% | $6.83B-0.2% | $6.85B |
| 매출총이익 | $3.64B+3.1% | $3.54B+2.0% | $3.46B-6.9% | $3.72B |
| 영업이익 | $1.48B-0.6% | $1.49B+10.2% | $1.35B-16.6% | $1.62B |
| 순이익 | $1.30B+1.1% | $1.29B+4.0% | $1.24B-1.1% | $1.25B |
| 희석 EPS | $4.57+3.2% | $4.43+5.7% | $4.19+0.2% | $4.18 |
| EBITDA | $1.83B-2.1% | $1.87B+9.9% | $1.71B-10.5% | $1.91B |
| 영업현금흐름 | $1.56B-11.0% | $1.75B-1.2% | $1.77B+35.1% | $1.31B |
| 잉여현금흐름 | $1.15B-16.1% | $1.37B-6.9% | $1.47B+44.4% | $1.02B |
| 총자산 | $12.73B+7.4% | $11.85B+10.1% | $10.76B+2.2% | $10.53B |
| 총부채 | $3.35B-1.1% | $3.39B+23.9% | $2.73B-1.2% | $2.77B |
최신 연도 우선 · 작은 퍼센트는 직전 연도 대비 변화입니다.
캘린더
A 실적·배당 일정
매출 하단
$1.98B
EPS 하단
$1.71
매출 상단
$2.00B
배당 지급일
2026-07-22
41일 전
실적 발표일
2026-11-25
D-85
EPS 상단
$1.76
매출 컨센서스
$1.99B
EPS 컨센서스
$1.73
배당락일
2026-06-30
63일 전
최근 배당
| 배당락일 | 주당 배당 |
|---|---|
| Jun 30, 2026 | $0.2550 |
| Mar 31, 2026 | $0.2550 |
| Jan 6, 2026 | $0.2550 |
| Sep 30, 2025 | $0.2480 |
| Jul 1, 2025 | $0.2480 |
| Apr 1, 2025 | $0.2480 |
| Dec 31, 2024 | $0.2480 |
| Oct 1, 2024 | $0.2360 |
뉴스
A 관련 최신 기사
실적Agilent (A) Q3 2026 Earnings Call Transcript
Pharma revenue surged 12% while advanced therapeutics grew nearly 30%, beating guidance.
Motley Fool · Aug 31, 2026
실적International Markets and Agilent (A): A Deep Dive for Investors
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Zacks · Aug 31, 2026
실적Agilent (NYSE) Expanded Non-GAAP Margin 320 bps. How Much Is Repeatable?
Agilent Technologies, Inc. (NYSE:A) delivered fiscal third-quarter revenue of $1.88 billion, an increase of 8.1% from a year earlier. Core revenue, which excludes currency movements and recent acquisitions and divestitures, grew 7.3%. The company-defined non-GAAP operating margin of Agilent Technologies, Inc. (NYSE:A) reached 28.3%, expanding 320 basis points year over year. Approximately 110 basis points […]
Insider Monkey · Aug 29, 2026
실적A Q2 Deep Dive: Product Momentum, China Recovery, and Operating Leverage Drive Results
Life sciences tools company Agilent Technologies (NYSE:A) announced better-than-expected revenue in Q2 CY2026, with sales up 8.1% year on year to $1.88 billion. Guidance for next quarter’s revenue was better than expected at $1.99 billion at the midpoint, 1% above analysts’ estimates. Its non-GAAP profit of $1.62 per share was 9% above analysts’ consensus estimates.
StockStory · Aug 28, 2026
실적Agilent Technologies (A) Has Investors Looking Closer After Its Latest Update
Agilent Technologies (A) is back in focus after raising its fiscal 2026 revenue guidance to a range of $7.49b to $7.51b, alongside fresh fourth quarter projections tied to its latest earnings release. The raised 2026 guidance and stronger recent quarters have come alongside a clear shift in how the market is pricing Agilent Technologies, with a 30 day share price return of 12.20% and a 1 year total shareholder return of 27.21%, which points to building momentum rather than fading...
Simply Wall St. · Aug 27, 2026
- 실적
Should Agilent’s (A) Upgraded 2026 Outlook and Margin Gains Require Action From Investors?
Earlier this week, Agilent Technologies reported third-quarter fiscal 2026 results showing higher sales and earnings year on year, and raised its full-year 2026 revenue guidance to US$7.49 billion–US$7.51 billion alongside issuing fourth-quarter revenue guidance of US$1.98 billion–US$2.00 billion. Management pointed to strong demand in pharma, China, and applied markets, plus efficiency gains from its Ignite program, as key drivers behind the improved outlook and margin expansion. We’ll now...
Simply Wall St. · Aug 27, 2026
실적Agilent Technologies, Inc. Q3 2026 Earnings Call Summary
Moby summary of Agilent Technologies, Inc.'s Q3 2026 earnings call
Moby · Aug 27, 2026
실적Agilent shares rise as strong Q3 results and improving demand support guidance upgrade
Agilent Technologies Inc (NYSE:A) delivered third-quarter earnings and revenue ahead of analyst forecasts and raised its fiscal 2026 guidance, supported by improving end markets and healthy demand for its laboratory technologies. Shares gained more than 3% in premarket trading on Thursday following the update.
InvestorsHub · Aug 27, 2026
- 실적
Agilent Technologies Inc (A) (Q3 2026) Earnings Call Highlights: Strong Core Growth and Raised ...
Agilent Technologies Inc (A) reports 7.3% core revenue growth and raises full-year EPS outlook, driven by robust pharma and China performance.
GuruFocus.com · Aug 27, 2026
실적Agilent Technologies Q3 Earnings Call Highlights
Agilent Technologies (NYSE:A) reported third-quarter fiscal 2026 revenue of $1.88 billion, with core revenue growth of 7.3%, exceeding the high end of its guidance range. The company said earnings per share were $1.56 excluding tariff-refund benefits, up 14% from a year earlier and $0.06 above the t
MarketBeat · Aug 26, 2026
홀더
A 내부자·기관 보유 현황
최신 보고 목록 기준이며 실제 거래 시점과 보고일 사이에는 시차가 있습니다.
기관 보유
95.4%
기관 보유 (유동주식)
95.6%
내부자 보유
0.2%
기관 수
1,602
주요 기관 홀더
| 홀더 | 주식 수 | 평가액 | 지분 | 변동 | 보고일 |
|---|---|---|---|---|---|
| Blackrock Inc. | 25.60M | $3.93B | 9.1% | -1.2% | Jun 30, 2026 |
| Vanguard Capital Management LLC | 18.45M | $2.83B | 6.5% | 0.4% | Jun 30, 2026 |
| Vanguard Portfolio Management LLC | 14.44M | $2.22B | 5.1% | 0.6% | Jun 30, 2026 |
| State Street Corporation | 12.85M | $1.97B | 4.6% | 0.7% | Jun 30, 2026 |
| Massachusetts Financial Services Co. | 10.01M | $1.54B | 3.5% | -20.7% | Jun 30, 2026 |
| T. Rowe Price Investment Management, Inc. | 7.76M | $1.19B | 2.8% | -13.7% | Jun 30, 2026 |
| Geode Capital Management, LLC | 7.60M | $1.17B | 2.7% | 1.0% | Jun 30, 2026 |
| Wellington Management Group, LLP | 7.45M | $1.14B | 2.6% | 2.7% | Jun 30, 2026 |
| Deutsche Bank AG | 7.01M | $1.08B | 2.5% | 17.1% | Jun 30, 2026 |
| Bank Of New York Mellon Corporation | 5.23M | $803.73M | 1.8% | 87.4% | Jun 30, 2026 |
면책조항: 증시가격은 모든 주식 시장의 최신 증시가격을 표시하는 것은 아니며, 정보가 지연되거나 잘못될 수 있습니다. 거래 목적이나 조언이 아닌 정보 제공 목적으로만 제공됩니다.